IO Biotech Ownership | Who Owns IO Biotech?
IO Biotech Ownership Summary
IO Biotech is owned by 14.99% institutional investors, 0.29% insiders, and 84.72% retail investors. Vivo capital is the largest institutional shareholder, holding 9.37% of IOBT shares. HBM Healthcare Investments AG Ord is the top mutual fund, with 5.99% of its assets in IO Biotech shares.
IOBT Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | IO Biotech | 14.99% | 0.29% | 84.72% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Vivo capital | 6.17M | 9.37% | $5.68M |
Novo | 3.35M | 5.09% | $3.09M |
Pfm health sciences, lp | 2.34M | 3.55% | $2.15M |
Marshall wace, llp | 2.11M | 3.20% | $1.94M |
Morgan stanley | 1.97M | 2.99% | $2.31M |
Bank of america corp /de/ | 1.65M | 2.51% | $1.93M |
Alyeska investment group | 987.65K | 1.50% | $1.16M |
Pivotal bioventure partners investment advisor | 864.20K | 1.31% | $795.06K |
Landscape capital management | 442.20K | 0.67% | $406.82K |
Soleus capital management | 192.67K | 0.29% | $177.26K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Vivo capital | 6.17M | 0.64% | $5.68M |
Pivotal bioventure partners investment advisor | 864.20K | 0.54% | $795.06K |
Novo | 3.35M | 0.19% | $3.09M |
Pfm health sciences, lp | 2.34M | 0.13% | $2.15M |
Sectoral asset management | 75.00K | 0.05% | $69.00K |
Landscape capital management | 442.20K | 0.04% | $406.82K |
Soleus capital management | 192.67K | 0.01% | $177.26K |
Alyeska investment group | 987.65K | 0.01% | $1.16M |
Bridgeway capital management | 174.00K | 0.00% | $160.08K |
Marshall wace, llp | 2.11M | 0.00% | $1.94M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Landscape capital management | 442.20K | 0.04% | 442.20K |
Sectoral asset management | 75.00K | 0.05% | 75.00K |
Royal bank of canada | 60.00K | - | 60.00K |
Vontobel | 32.67K | 0.00% | 32.67K |
Citadel advisors | 86.89K | - | 28.27K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Samsara biocapital | - | - | -3.64M |
Armistice capital | - | - | -1.54M |
Logos global management lp | - | - | -493.83K |
Fmr | - | - | -314.60K |
Morgan stanley | 1.97M | 0.00% | -224.89K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Landscape capital management | 442.20K | 0.04% | 442.20K | $406.82K |
Sectoral asset management | 75.00K | 0.05% | 75.00K | $69.00K |
Royal bank of canada | 60.00K | - | 60.00K | $55.00K |
Vontobel | 32.67K | 0.00% | 32.67K | $30.05K |
Two sigma securities | 12.38K | 0.00% | 12.38K | $11.39K |
Sold Out
Holder | Change |
---|---|
Advisor group | -230.00 |
Redwood wealth management group | -4.17K |
Virtu financial | -17.95K |
Wealth enhancement advisory services | -20.00K |
Two sigma investments, lp | -30.00K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 12 | -36.84% | 9,874,693 | -58.14% | 14 | 1.17% | 7 | -12.50% | - | -100.00% |
Sep 30, 2024 | 18 | -10.00% | 23,573,928 | -9.96% | 35 | 2.27% | 7 | 16.67% | 2 | -50.00% |
Jun 30, 2024 | 20 | 11.11% | 26,183,049 | -4.24% | 39 | 1.01% | 6 | 20.00% | 4 | -20.00% |
Mar 31, 2024 | 18 | -5.26% | 27,341,910 | -7.00% | 62 | 1.83% | 5 | -28.57% | 5 | 25.00% |
Dec 31, 2023 | 19 | -5.00% | 29,400,721 | -0.90% | 58 | 0.55% | 7 | -41.67% | 4 | 100.00% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
HBM Healthcare Investments AG Ord | 3.94M | 5.99% | - |
MEDICAL BioHealth EUR Acc | 679.10K | 1.03% | 7.40K |
Fidelity Select Biotechnology | 314.60K | 0.48% | - |
Bridgeway Ultra-Small Company Market | 174.00K | 0.26% | -25.00K |
Protea Sectoral Biotech Opps IF USD Acc | 75.00K | 0.11% | - |
Fidelity Nasdaq Composite Index | 33.31K | 0.05% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Dec 23, 2024 | Ahmad Qasim Iftikhar | Chief Medical Officer | Buy | $26.55K |
Dec 23, 2024 | Zocca Mai-Britt | Chief Executive Officer | Buy | $10.12K |
Dec 23, 2024 | Sullivan Amy | Chief Financial Officer | Buy | $8.48K |
Dec 23, 2024 | Smith Devin Whittemore | General Counsel | Buy | $9.72K |
Jul 25, 2024 | Novo Holdings A/S | - | Sell | $68.34K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | 3 | - |
2024 Q3 | - | 2 |
2024 Q2 | - | 1 |
2024 Q1 | - | 1 |
2023 Q4 | 2 | - |
IOBT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools